Director, New Product Commercialization

Role Summary

The Director, New Product Commercialization is responsible for commercial input into lifecycle strategy, business development, as well as product and portfolio assessments across small-molecules, gene therapies, peptides and antibodies in one of four therapeutic areas: Neurology, Neuroimmunology, Neuroendocrinology or Psychiatry. Responsibilities include active participation in early commercial planning and market research for Neurocrine's therapeutic candidates from early-stage pre-clinical development through early phase three. Key workstreams include market opportunity assessments, patient journey and lifecycle prioritization for current and potential pipeline programs with emphasis on disease area understanding, competitive landscapes, unmet medical need, reimbursement environment and overall commercial attractiveness. This individual will lead commercial insights for development programs across stage gates in the drug development process.

Responsibilities

• Plans and conducts market research and analyses to maximize the value of product candidates and research programs in existing and new therapeutic areas
• Defines Target Product Profiles (TPPs) for cross-functional R&D teams developing novel therapeutic candidates to help inform asset opportunities
• Works in conjunction with Clinical Development and Medical Affairs, to identify and gain insights from scientific thought leaders as needed to inform clinical and commercial development plans
• Supports Business Development activities, including commercial due diligence on licensing, acquisition and collaboration opportunities
• Participates in the development of revenue forecasts and risk-adjusted net present value (NPV) models for all portfolio compounds in collaboration with key business partners (Finance, Clinical Development, etc.)
• Partners with cross-functional colleagues to help support lifecycle management (LCM) activities and decision-making
• Provides customer insights and recommendations to help inform clinical development including formulations, dosing, desired endpoints, evidence generation plans and other elements impacting product labeling and overall commercial viability
• Works closely with HEOR and Market Access teams to build in appropriate levels of evidence generation and differentiation for optimal access both in the US and globally
• Monitors competitive therapies of relevance to Neurocrine to allow development teams to react to new information by strengthening underlying product candidate profiles
• Conducts assessments of ex-US commercial potential, develops early commercial launch plans and assists with partnership discussions in support of Business Development colleagues
• Actively participates on cross-functional product development sub-teams

Qualifications

• Bachelor’s degree is required, with a neuroscience concentration preferred; PhD, MBA or advanced degree a plus, with education in marketing or other business disciplines highly desirable
• A minimum of 5-10 years of experience in new product commercialization, management consulting, business development or related disciplines in biotechnology or pharmaceutical industries
• Thorough knowledge of new product commercialization and in-line brand management principals appropriate to pharmaceutical or biologic therapeutics
• Exceptional command of data analytics, forecasting and market research techniques with a proven ability to interpret market insights to help guide strategic decision-making
• Outstanding communication and presentation skills include strong written and oral communication abilities
• Demonstrated cross-functional leadership and ability to partner with colleagues across the business and scientific areas of the organization
• Excellent teamwork and interpersonal skills
• Knowledge of biotechnology or pharmaceutical market, including pricing, reimbursement and market access principles across multiple geographic regions